Quantcast
Channel: False Claims Act (FCA) – Corporate Compliance Insights
Browsing latest articles
Browse All 70 View Live

The Trump Administration Allowed an Estimated $84B in EIDL and PPP Fraud. Now...

The Biden administration, in a March memo, estimated EIDL and PPP fraud has totaled $84 billion to date. Numerous federal entities and civil servants have been empowered to investigate. Organizations...

View Article



Big Data Anomalies Can’t Be Used to Prosecute. But Identifying Them Can Help...

In a recent Ninth Circuit Court of Appeals case, prosecutors tried to stake their argument on their analysis of anomalies in big datasets. It didn’t work. The proceedings nevertheless highlight how...

View Article

The False Claims Amendment Act of 2021 – A New Paradigm in Contracting with...

The Escobar decision paved the way for a potential loophole in the False Claims Act that U.S. senators aim to close. If passed, the False Claims Amendments Act of 2021 will fundamentally shift the...

View Article

Apotex, Sandoz, Taro to Pay $447M Over FCA Violations Involving Price-Fixing...

The Justice Department’s probe into the generic pharmaceutical industry has resulted in three new settlements. Each arose from deferred prosecution agreements over violations of the False Claims Act...

View Article

CCOs Say the Opaque Nature of DOJ Incentives Makes Self-Reporting a Hard Sell

Results of a recent Ethics and Compliance Initiative (ECI) survey indicate that a majority of CCOs can’t be sure whether DOJ follows its own guidance when accounting for self-reporting and other...

View Article


DOJ’s Civil Cyber Fraud Initiative Could Find Health Care Companies Exposed...

The Biden Administration and DOJ intend to pursue cyber fraud through the False Claims Act (FCA), with an emphasis on whistleblower reporting. The implications could be devastating for unsuspecting...

View Article

What Healthcare Providers and Life Sciences Companies Can Expect for...

Though the Biden administration’s first year kept enforcements light, broad shifts and specific measures taken by regulators are set to affect the health care and life sciences industry through 2022....

View Article

Farewell to Blue Bell

Once, Blue Bell Ice Cream was the pride of Texas. But a 2015 listeriosis outbreak in “the little creamery in Brenham” revealed board-level contamination of a different sort. Unethical practices were...

View Article


Novartis: Corruption Across the Globe

Swiss pharmaceutical giant Novartis has recently been on the receiving end of two significant enforcement actions: the first for violations of the Foreign Corrupt Practices Act; the second for...

View Article


Codes of Conduct: Life Is Hard, But It’s Harder When You’re Dumb

More often than not, companies stumble into one or more of the health care compliance bear traps out of ignorance rather than malfeasance. Jim Nortz discusses the key role sales and marketing codes of...

View Article
Browsing latest articles
Browse All 70 View Live




Latest Images